BCG therapy—the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated ...

Detalimogene voraplasmid gains FDA RMAT designation, showcasing a 71% response rate in treating high-risk, BCG-unresponsive ...

Bladder cancer, often misunderstood, affects both men and women, not just the elderly. While smoking is a significant risk ...

A comprehensive carcinogenicity study on the world's most used herbicide, glyphosate, involving scientists from Europe and ...

The median time to treatment initiation is increasing across cancer types, and this appears to be driven by an increase in stage I cancer diagnoses, data suggest.

Donald A. Newell passed away peacefully on the afternoon of June 22nd,2025 after facing metastatic bladder cancer with ...

CG Oncology, Inc.'s promising bladder cancer therapy, strong financials, and unique therapeutic profile make it a compelling ...

Bladder cancer has earned the title as the "forgotten cancer" despite being the fifth most common in Canada. According to the Canadian Cancer Society, it's estimated that in 2024, 12,300 Canadians ...

If you have bladder cancer, there are several treatment options.Your doctor will help you decide which one is best for you. Choosing the best treatment depends on a number of things, including ...

Bladder cancer usually takes a long time to develop, so it is most common in older people. Almost 60 out of 100 (almost 60%) of new cases are in people aged 75 and over. It is rare in people under 40.

Bladder cancer happens when cells inside the organ grow out of control. Fortunately, it’s rare. WebMD explains what it is and what factors put you at risk.

Bladder cancer affects approximately 83,000 Americans each year, yet remains one of the most overlooked forms of cancer despite having excellent survival rates when caught early.